- |||||||||| Trial completion, Enrollment change: PTI PARI: Study of Immune Thrombocytopenia Pathogenesis: (clinicaltrials.gov) - Mar 15, 2018
P=N/A, N=89, Completed, Trial completion date: Feb 2018 --> Dec 2018 | Trial primary completion date: Feb 2018 --> Jul 2017 Recruiting --> Completed | N=175 --> 89
- |||||||||| Phase classification, Trial termination, Trial primary completion date: Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) - Jan 9, 2018
P=N/A, N=30, Terminated, Trial primary completion date: Dec 2008 --> May 2009 Phase classification: P2 --> P=N/A | Suspended --> Terminated | Trial primary completion date: Jan 2017 --> Dec 2017; problem with the candidate (investigator)
- |||||||||| cetirizine oral / Generic mfg.
Enrollment change, Trial termination: Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching (clinicaltrials.gov) - Nov 9, 2017 P4, N=3, Terminated, Phase classification: P2 --> P=N/A | Suspended --> Terminated | Trial primary completion date: Jan 2017 --> Dec 2017; problem with the candidate (investigator) N=73 --> 3 | Recruiting --> Terminated; Unable to recruit patients
- |||||||||| Enrollment change, Trial withdrawal: Single Incision Versus Standard Laparoscopic Splenectomy (clinicaltrials.gov) - Feb 3, 2017
P=N/A, N=0, Withdrawn, Initiation date: Jun 2011 --> Jun 2012 | Trial primary completion date: Jun 2013 --> Jul 2016 N=30 --> 0 | Active, not recruiting --> Withdrawn
- |||||||||| Promacta (eltrombopag) / Novartis
Trial completion, Trial primary completion date: Promacta Pregnancy Registry (clinicaltrials.gov) - Jul 25, 2016 P=N/A, N=1, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jan 2016 --> Jul 2014
- |||||||||| Trial primary completion date: Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) - Jul 19, 2016
P2, N=30, Suspended, Recruiting --> Completed | Trial primary completion date: Jan 2016 --> Jul 2014 Trial primary completion date: Jan 2016 --> Jan 2017
- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Trial completion, Enrollment change, Trial primary completion date, Combination therapy: rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP (clinicaltrials.gov) - Apr 21, 2016 P3, N=123, Completed, N=199 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=240 --> 123 | Trial primary completion date: Sep 2013 --> Dec 2013
- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Trial completion, Enrollment change, Trial primary completion date, Combination therapy: Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) (clinicaltrials.gov) - Apr 21, 2016 P3, N=91, Completed, Recruiting --> Completed | N=240 --> 123 | Trial primary completion date: Sep 2013 --> Dec 2013 Recruiting --> Completed | N=200 --> 91 | Trial primary completion date: Sep 2012 --> Aug 2013
|